Table 2 Updated/started Cochrane reviews as a result of NIHR HTA Grant (14/27/02) [49]
From: Study-based registers reduce waste in systematic reviewing: discussion and case report
Anticholinergic medication for antipsychotic-induced tardive dyskinesia [53] | |
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia [54] | |
Benzodiazepines for antipsychotic-induced tardive dyskinesia [55] | |
Calcium channel blockers for antipsychotic-induced tardive dyskinesia [56] | |
Cholinergic medication for antipsychotic-induced tardive dyskinesia [57] | |
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia [58] | |
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia [59] | |
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia [60] | |
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesiaa [61] | |
Vesicular monoamine transporter inhibitors versus placebo for antipsychotic-induced tardive dyskinesiab [62] | |
Vitamin E for antipsychotic-induced tardive dyskinesia [63] |